Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC)

CompletedOBSERVATIONAL
Enrollment

52

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions
Colorectal NeoplasmsAdvanced Metastatic Colorectal Cancer
Trial Locations (1)

Unknown

13 sites within US, Incl Greenville, SC and Tyler, TX

All Listed Sponsors
collaborator

Quintiles, Inc.

INDUSTRY

lead

US Oncology Research

INDUSTRY

NCT01909362 - Biomarker Analysis for Patients With Metastatic Colorectal Cancer (MCC) | Biotech Hunter | Biotech Hunter